James Hong

CEO, Director

Mr. Hong has dedicated over 15 years to medical device innovation. Prior to Solinas, Mr. Hong was a R&D consultant at Sadra Medical, a transcatheter valve company, acquired by Boston Scientific. Prior to Sadra, he was Director of R&D at Arbor Surgical Technologies Inc, a minimally invasive aortic valve replacement company. Mr. Hong also held senior R&D engineering positions at Paracor Medical and Guidant Corp, medical device companies developing novel therapies for cardiac and cardiovascular diseases. Mr. Hong started his career at Beth Israel’s Deaconess Medical Center Orthopaedic Biomechanics Laboratory, where he developed methods of using non-invasive imaging modalities as quantitative tools. Subsequently, Mr. Hong joined the Cardiac Biomechanics Laboratory at the San Francisco VA Medical Center, developing computational models to better understand the mechanical effects of surgical therapies on congestive heart failure. Mr. Hong holds a Bachelor and Master of Science degrees in Mechanical Engineering from Purdue University and Massachusetts Institute of Technology, respectively. He has nine issued and five pending U.S. patents and six published peer-reviewed journal articles.

Erik van der Burg

Executive Chairman

Mr. van der Burg has spent the last 25 years developing a variety of medical devices and technology. Most of that time has been spent in development stage, pre-commercialization companies. Besides his role at Solinas, he is the Chairman, CTO and Co-founder of Siesta Medical, which is developing and commercializing minimally invasive treatments for obstructive sleep apnea and serves as a member on the Santa Clara University Bioengineering advisory board. He also co-founded and served as CEO of Ross Creek Medical (acquired by Stryker). Ross Creek was a highly capital efficient company that developed novel soft tissue fixation technologies that were designed to improve the strength and simplicity of the reattachment of soft tissue to bone. Prior to Ross Creek, he was co-founder and CEO of Aspire Medical, which launched after he served as an entrepreneur-in-residence at Three Arch Partners. Previously, he was co-founder and Vice President of Research and Development for Appriva Medical (acquired by ev3, Inc.), and served as Director of R&D at Prograft Medical (acquired by W.L. Gore) Mr. van der Burg earned his B.S.M.E. from Cal Poly University, San Luis Obispo, and an M.S.M.E. from Santa Clara University. He is an inventor on over 50 patents in the medical device field.

Michael Kolber

VP of Regulatory Affairs

Mr. Kolber has over 20 years experience in life sciences product development. He serves as VP, Clinical and Regulatory Affairs at Biocardia, Inc a biotherapeutic company focusing on regenerative medicine (RM) solutions for cardiovascular disease. Earlier he was VP, Regulatory Affairs and Quality Assurance at Paracor Medical, Inc., a developer of a surgical approach for treating heart failure. Mr. Kolber also previously served as VP, Clinical Affairs, Regulatory Affairs and Quality Assurance at Appriva Medical (acquired by ev3). Prior to this, he was VP, Regulatory Affairs and Quality Assurance at Prograft Medical (acquired by W.L. Gore). Mr. Kolber holds a B.S. in Zoology from San Diego State University, an M.P.H from UCLA, and an M.B.A. from Saint Mary’s College of Moraga.

Eric Coblin

VP of Operations & Quality Assurance

Mr. Coblin has 14 years of experience in Operations, Manufacturing and Quality roles in the Medical Device industry. Prior to joining Solinas he was Senior Director of Manufacturing and Quality Assurance at ReVascular Therapeutics, a chronic total occlusion technology company. Following acquisition by Boston Scientific Mr. Coblin led operations for product launch and ramp up through transfer to a core Boston Scientific production site. Prior to that he was Operations Manager for Coalescent Surgical, an anastomic device company acquired by Medtronic, where he led production and supply chain efforts for over $10 million dollars of annual revenue. Mr. Coblin began his career as a Manufacturing Engineer with Prograft Medical, a stent-graft company acquired by W.L. Gore. Mr. Coblin holds a B.S. degree in Mechanical Engineering from Northwestern University and a M.Sc. in Manufacturing Systems Engineering from Stanford University.

Amy Lee

Sr. R&D Manager

Ms. Lee has over 10 years of experience in cardiovascular device design, development, and manufacturing. Ms. Lee was most recently an R&D engineer at Abbott Vascular Structural Heart (formerly eValve) as technical lead for the next generation steering catheter subsystem. Prior to Abbott, she worked at Nellix Inc. (acquired by Endologix) to design and develop a novel vascular graft implant to treat abdominal aneurysmal disease, and at Terumo Cardiovascular Systems to develop and implement production of disposable products for cardiovascular bypass procedures. Ms. Lee holds a B.S. in Mechanical Engineering from the University of Maryland, and an M.S. in Biomechanical Engineering from Stanford University. She has been issued five U.S. patents.